• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过 PLGA 纳米粒/温敏壳聚糖水凝胶双重递药系统实现左氧氟沙星和醋酸泼尼松龙的术后给药:一项体外和体内研究。

Development of a dual delivery of levofloxacin and prednisolone acetate via PLGA nanoparticles/ thermosensitive chitosan-based hydrogel for postoperative management: An in-vitro and ex-vivo study.

机构信息

Department of Materials Science and Engineering, National Taiwan University of Science and Technology, Taipei, Taiwan.

Department of Ophthalmology, Taipei Veterans General Hospital, Taipei, Taiwan; National Yang-Ming University School of Medicine, Faculty of Medicine, Taipei, Taiwan.

出版信息

Int J Biol Macromol. 2021 Jun 1;180:365-374. doi: 10.1016/j.ijbiomac.2021.03.017. Epub 2021 Mar 4.

DOI:10.1016/j.ijbiomac.2021.03.017
PMID:33676980
Abstract

Post-operative endophthalmitis (POE) is one of the most dreadful complications after intraocular surgery. For cataract surgery patients, both commercially available topical 0.5% levofloxacin and 1% prednisolone acetate (PA) ophthalmic solution require at least 3 to 4 times application daily. In this study, we develop a dual drug delivery system composed of the thermosensitive chitosan/gelatin-based hydrogel containing PA and levofloxacin-loaded nanoparticles (LNPs). LNPs with negative surface charge show the monodisperse (polydispersity index 0.045), nanosize (154.7 nm) and sphere-like structure. The optimal concentration of LNPs and PA to corneal epithelial cells was 5 μg/mL and 50 μg/mL, respectively. The developed dual drug delivery system (PAgel-LNPs) could gel at 34 °C within 63 s. The osmolarity of PAgel-LNPs was 301.2 ± 1.5 mOsm/L. PAgel-LNPs showed a sustained-release profile for 7 days. Post-treatment of PAgel-LNPs in TNF-α-damaged corneal epithelial cells could decrease the inflammation (inflammatory genes (TNF-α, IL-6, MMP-3 andMMP-9) and IL-6 production) and cell death. In ex-vivo rabbit model of S. aureus keratitis, the anti-inflammation and anti-bacterial property have been demonstrated. These results suggest that thermosensitive PAgel-LNPs may have the potential to use for the prevention of POE.

摘要

术后眼内炎(POE)是眼内手术后最可怕的并发症之一。对于白内障手术患者,市售的 0.5%左氧氟沙星和 1%醋酸泼尼松龙(PA)滴眼液每天至少需要应用 3 至 4 次。在这项研究中,我们开发了一种由含有 PA 和载左氧氟沙星纳米粒(LNPs)的温敏壳聚糖/明胶基水凝胶组成的双药物递送系统。带负电荷的 LNPs 显示单分散性(多分散指数0.045)、纳米尺寸(154.7nm)和类球形结构。LNPs 和 PA 对角膜上皮细胞的最佳浓度分别为 5μg/mL 和 50μg/mL。所开发的双药物递送系统(PAgel-LNPs)可在 34°C 下在 63s 内凝胶。PAgel-LNPs 的渗透压为 301.2±1.5mOsm/L。PAgel-LNPs 表现出 7 天的持续释放特征。在 TNF-α损伤的角膜上皮细胞中,PAgel-LNPs 的处理可以减少炎症(炎症基因(TNF-α、IL-6、MMP-3 和 MMP-9)和 IL-6 的产生)和细胞死亡。在金黄色葡萄球菌角膜炎的离体兔模型中,已经证明了抗炎和抗菌特性。这些结果表明,温敏 PAgel-LNPs 可能具有用于预防 POE 的潜力。

相似文献

1
Development of a dual delivery of levofloxacin and prednisolone acetate via PLGA nanoparticles/ thermosensitive chitosan-based hydrogel for postoperative management: An in-vitro and ex-vivo study.通过 PLGA 纳米粒/温敏壳聚糖水凝胶双重递药系统实现左氧氟沙星和醋酸泼尼松龙的术后给药:一项体外和体内研究。
Int J Biol Macromol. 2021 Jun 1;180:365-374. doi: 10.1016/j.ijbiomac.2021.03.017. Epub 2021 Mar 4.
2
Sustained release of levofloxacin from thermosensitive chitosan-based hydrogel for the treatment of postoperative endophthalmitis.载左氧氟沙星的温敏壳聚糖水凝胶的制备及其用于治疗术后眼内炎。
J Biomed Mater Res B Appl Biomater. 2020 Jan;108(1):8-13. doi: 10.1002/jbm.b.34359. Epub 2019 Mar 21.
3
Glycol chitosan/oxidized hyaluronic acid hydrogel film for topical ocular delivery of dexamethasone and levofloxacin.用于局部眼部递送达氟沙星和地塞米松的乙二醇壳聚糖/氧化透明质酸水凝胶膜。
Int J Biol Macromol. 2021 Jan 15;167:659-666. doi: 10.1016/j.ijbiomac.2020.11.214. Epub 2020 Dec 2.
4
Co-delivery of metformin and levofloxacin hydrochloride using biodegradable thermosensitive hydrogel for the treatment of corneal neovascularization.载盐酸二甲双胍和左氧氟沙星的生物可降解温敏水凝胶治疗角膜新生血管。
Drug Deliv. 2019 Dec;26(1):522-531. doi: 10.1080/10717544.2019.1609623.
5
Injectable Chitosan-Based Thermosensitive Hydrogel/Nanoparticle-Loaded System for Local Delivery of Vancomycin in the Treatment of Osteomyelitis.可注射壳聚糖基温敏水凝胶/载药纳米粒子递药系统局部递送万古霉素治疗骨髓炎
Int J Nanomedicine. 2020 Aug 6;15:5855-5871. doi: 10.2147/IJN.S247088. eCollection 2020.
6
Ocular anti-inflammatory activity of prednisolone acetate loaded chitosan-deoxycholate self-assembled nanoparticles.醋酸泼尼松龙载壳聚糖-去氧胆酸钠自组装纳米粒的眼部抗炎活性。
Int J Nanomedicine. 2019 May 29;14:3679-3689. doi: 10.2147/IJN.S195892. eCollection 2019.
7
Eye drops and eye gels of levofloxacin: comparison of ocular absorption characterizations and therapeutic effects in the treatment of bacterial keratitis in rabbits.左氧氟沙星滴眼液和眼用凝胶:眼部吸收特征比较及治疗兔细菌性角膜炎的疗效观察。
Drug Dev Ind Pharm. 2020 Apr;46(4):673-681. doi: 10.1080/03639045.2020.1750626. Epub 2020 Apr 20.
8
Development of topical chitosan/ β-glycerophosphate-based hydrogel loaded with levofloxacin in the treatment of keratitis: An study.负载左氧氟沙星的壳聚糖/β-甘油磷酸酯局部水凝胶治疗角膜炎的研究:一项研究。
Heliyon. 2021 Dec 30;8(1):e08697. doi: 10.1016/j.heliyon.2021.e08697. eCollection 2022 Jan.
9
Thermosensitive chitosan-gelatin-based hydrogel containing curcumin-loaded nanoparticles and latanoprost as a dual-drug delivery system for glaucoma treatment.载姜黄素纳米粒和拉坦前列素的温敏性壳聚糖-明胶基水凝胶作为治疗青光眼的双重药物递送系统。
Exp Eye Res. 2019 Feb;179:179-187. doi: 10.1016/j.exer.2018.11.017. Epub 2018 Nov 22.
10
Formulation and optimization of levofloxacin loaded chitosan nanoparticle for ocular delivery: In-vitro characterization, ocular tolerance and antibacterial activity.载左氧氟沙星壳聚糖纳米粒的制备及优化及其眼部给药: 体外特性、眼内耐受性和抗菌活性。
Int J Biol Macromol. 2018 Mar;108:650-659. doi: 10.1016/j.ijbiomac.2017.11.170. Epub 2017 Dec 22.

引用本文的文献

1
Frontier applications of retinal nanomedicine: progress, challenges and perspectives.视网膜纳米医学的前沿应用:进展、挑战与展望
J Nanobiotechnology. 2025 Feb 25;23(1):143. doi: 10.1186/s12951-025-03095-6.
2
Biopolymeric Innovations in Ophthalmic Surgery: Enhancing Devices and Drug Delivery Systems.眼科手术中的生物聚合物创新:改进器械与药物递送系统
Polymers (Basel). 2024 Jun 16;16(12):1717. doi: 10.3390/polym16121717.
3
Thermo-Responsive Sol-Gel-Based Nano-Carriers Containing Terbinafine HCl: Formulation, In Vitro and Ex Vivo Characterization, and Antifungal Activity.
含盐酸特比萘芬的基于热响应溶胶-凝胶的纳米载体:制剂、体外和离体表征以及抗真菌活性
Gels. 2023 Oct 20;9(10):830. doi: 10.3390/gels9100830.
4
Nanocomposite Hydrogels: An Optimistic Insight Towards the Treatments of Ocular Disorders.纳米复合水凝胶:对眼部疾病治疗的乐观见解。
Recent Pat Nanotechnol. 2025;19(2):205-215. doi: 10.2174/1872210517666230731102130.
5
A New Era in Ocular Therapeutics: Advanced Drug Delivery Systems for Uveitis and Neuro-Ophthalmologic Conditions.眼科治疗的新时代:用于葡萄膜炎和神经眼科疾病的先进药物递送系统
Pharmaceutics. 2023 Jul 14;15(7):1952. doi: 10.3390/pharmaceutics15071952.
6
Overview of Antimicrobial Biodegradable Polyester-Based Formulations.概述抗菌可生物降解聚酯基配方。
Int J Mol Sci. 2023 Feb 2;24(3):2945. doi: 10.3390/ijms24032945.
7
Research Progress of Bioinspired Nanostructured Systems for the Treatment of Ocular Disorders.用于治疗眼部疾病的仿生纳米结构系统的研究进展
Pharmaceuticals (Basel). 2023 Jan 10;16(1):96. doi: 10.3390/ph16010096.
8
Immune modulating nanoparticles for the treatment of ocular diseases.免疫调节纳米颗粒治疗眼部疾病。
J Nanobiotechnology. 2022 Nov 24;20(1):496. doi: 10.1186/s12951-022-01658-5.
9
Polymeric Nanoparticles-Loaded Hydrogels for Biomedical Applications: A Systematic Review on In Vivo Findings.用于生物医学应用的载聚合物纳米颗粒水凝胶:关于体内研究结果的系统综述
Polymers (Basel). 2022 Mar 2;14(5):1010. doi: 10.3390/polym14051010.